UroGen Pharma Ltd (NASDAQ:URGN) Drops -21.77%, But Further Rally Could Be Imminent
In recent trading session, UroGen Pharma Ltd (NASDAQ:URGN) saw 2.69 million shares changing hands at last check today with its beta currently measuring 0.59. Company’s